AVTE - Aerovate Therapeutics slides after its hypertension treatment fails to meet main goal June, 17 2024 09:22 AM Aerovate Therapeutics Inc. 2024-06-17 09:22:41 ET More on Aerovate Therapeutics Aerovate: Imatinib Delivery Change Leads To Targeting Of Massive PAH Market Seeking Alpha’s Quant Rating on Aerovate Therapeutics Historical earnings data for Aerovate Therapeutics Financial information for Aerovate Therapeutics For further details see: Aerovate Therapeutics slides after its hypertension treatment fails to meet main goal